PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,603,000 | -9.9% | 125,000 | 0.0% | 0.58% | -13.2% |
| Q4 2021 | $2,888,000 | -22.5% | 125,000 | 0.0% | 0.67% | -31.9% |
| Q3 2021 | $3,725,000 | -12.8% | 125,000 | 0.0% | 0.98% | -34.0% |
| Q2 2021 | $4,270,000 | +3.9% | 125,000 | 0.0% | 1.49% | -9.2% |
| Q1 2021 | $4,111,000 | -46.5% | 125,000 | 0.0% | 1.64% | -60.8% |
| Q4 2020 | $7,689,000 | – | 125,000 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |